Personalized radiation dosing for prostate cancer return
Part of Cancer, Kidney & urinary clinical trials.
This trial tests giving a higher dose of radiation to areas where prostate cancer has returned after surgery, while giving a lower dose to healthy nearby tissue, to reduce side effects while still treating the cancer effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had surgery to remove your prostate (radical prostatectomy) at least 6 months ago.
- A PSMA PET scan shows the cancer has come back in the prostate area or nearby lymph nodes.
- You are in good general health (able to do your daily activities).
- You have not had radiation to the pelvic area before, and the cancer has not spread to distant parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation treatments for prostate cancer that has not spread to lymph nodes or other parts of the body. It tests whether adding a higher dose of radiation to the main tumor helps control the cancer better than standard radiation alone.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This trial is testing a way to personalize radiation therapy for people with early-stage breast cancer. It may help make treatment more precise and reduce side effects.
This trial tests whether a special scan (PSMA PET) can help doctors aim and adjust radiation more precisely when prostate cancer returns after surgery. It may help by increasing dose to areas that look involved while lowering dose to uninvolved pelvic areas.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This trial compares two types of radiation for men who have had their prostate removed, to see if a dose tailored to their risk is just as good or better. It aims to reduce side effects while keeping the cancer from coming back.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.